Hexindai Inc. - ADR (HX) News
Filter HX News Items
HX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
HX News Highlights
- For HX, its 30 day story count is now at 3.
- Over the past 13 days, the trend for HX's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about HX are AGM, ROAD and YI.
Latest HX News From Around the Web
Below are the latest news stories about Xiaobai Maimai Inc that investors may wish to consider to help them evaluate HX as an investment opportunity.
Akso Health Group Announces Effective Date of Name Change and Ticker Symbol ChangeAkso Health Group ("Akso Health", the "Company" or "We") (NASDAQ: AHG), formerly known as Xiaobai Maimai Inc., today announced that the Company will update its name and ticker symbol on the Nasdaq Stock Market, effective at the start of trading on December 16, 2021 (the "Effective Date"). |
Akso Health Group Reports Unaudited Financial Results for First Half of Fiscal Year 2022Akso Health Group (NASDAQ: AHG) ("Akso Health", the "Company" or "we"), formerly known as Xiaobai Maimai Inc., a social e-commerce platform in China, today announced its unaudited condensed consolidated financial results for the six months ended September 30, 2021. |
Xiaobai Maimai Announces the Results of Annual General Meeting and Name ChangeXiaobai Maimai Inc. (NASDAQ: HX) ("Xiaobai Maimai" or the "Company"), today announced that it held the 2021 annual general meeting of shareholders (the "AGM") at the Meeting Room, Futian Shangri-La, 4088 Yi Tian Road, Futian District, Shenzhen 518408, People's Republic of China, at 10:00 a.m. (Beijing Time) on December 3, 2021. At the AGM, holders of 71,057,650 ordinary shares (including ordinary shares represented by the Company's American Depositary Shares), out of the 71,478,550 ordinary shar |
Xiaobai Maimai Appoints Dr. Yingxian Liu as Medical Consultant for We Health LimitedXiaobai Maimai Inc. (NASDAQ: HX) ("Xiaobai Maimai," the "Company," or "we"), today announced the appointment of Dr. Yingxian Liu as the medical consultant to the Company. Dr. Liu will work closely with management to develop the Company's cancer therapy and radiation oncology business by the Company's wholly-owned subsidiary, We Health Limited. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayI hope you're ready for another busy day of trading because we're starting it with the biggest pre-market stock movers for Wednesday. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayWelcome back, trader! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayGood morning, investor! |
Xiaobai Maimai Plans to Enter the U.S. Radiation Oncology Services MarketXiaobai Maimai Inc. (NASDAQ: HX) ("Xiaobai Maimai", the "Company", or "we"), a social e-commerce platform in China, today announced that it plans to enter the radiation oncology services market in the U.S. |
Xiaobai Maimai Files Annual Report on Form 20-F for Fiscal Year 2021Xiaobai Maimai Inc. (NASDAQ: HX), formerly known as Hexindai Inc. ("Xiaobai Maimai", the "Company", or "we"), a social e-commerce platform in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended March 31, 2021 with the U.S. Securities and Exchange Commission ("SEC") on July 28, 2021. The annual report on Form 20-F, which contains its audited financial statements, can be accessed on the SEC's website at http://www.sec.gov as well as via the Company's inves |
Xiaobai Miamai Contributed to the Drafting of "Social e-Commerce Enterprise Operational Service Standards", Officially Launched by CATIS in February 2021The "Social e-Commerce Enterprise Operational Service Standards" (the "Standards") was officially released by the Social e-Commerce Branch of China Association of Trade in Services (CATIS) in February 2021. Xiaobai Maimai Inc. (NASDAQ: HX), formerly known as Hexindai Inc. ("Xiaobai Maimai" or the "Company"), a social e-commerce platform in China, was one of the ten leading organizations that participated in the drafting of the Standards. The Standards defines the principle and business structure of social e-commerce services in China and outlines the fundamental requirements across the whole process of social e-commerce, from pre-transaction to after-sales customer services. Xiaobai Maimai's executives contributed their industry insights and efforts to formulate the Standards which aims... |